Concepedia

Huadong Sun

HS

Statistics

Publications

16

Citations

895

H-Index

12

Active since

2013

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Bristol-Myers Squibb (Sweden)

Sun Yat-sen University

The First Affiliated Hospital, Sun Yat-sen University

Huadong Sun is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, pharmacy, and drug discovery.

Publications per year

2013–2020

16

Publications

16

Highly Selective Inhibition of Tyrosine Kinase 2 (TYK2) for the Treatment of Autoimmune Diseases: Discovery of the Allosteric Inhibitor BMS-986165

Stephen T. Wrobleski, Ryan Moslin, Shuqun Lin et al. · Journal of Medicinal Chemistry · 2019 · 369 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Identification of <i>N</i>-Methyl Nicotinamide and <i>N</i>-Methyl Pyridazine-3-Carboxamide Pseudokinase Domain Ligands as Highly Selective Allosteric Inhibitors of Tyrosine Kinase 2 (TYK2)

Ryan Moslin, Yanlei Zhang, Stephen T. Wrobleski et al. · Journal of Medicinal Chemistry · 2019 · 92 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

A novel function of CXCL10 in mediating monocyte production of proinflammatory cytokines

Qihong Zhao, Taeg Kim, Jian Pang et al. · Journal of Leukocyte Biology · 2017 · 69 citations · Full text

Life Sciences, Immunology, Pathology +17

Identification of Imidazo[1,2-<i>b</i>]pyridazine Derivatives as Potent, Selective, and Orally Active Tyk2 JH2 Inhibitors

Chunjian Liu, James C. Lin, Ryan Moslin et al. · ACS Medicinal Chemistry Letters · 2019 · 53 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

A Novel, Fully Human Anti–fucosyl-GM1 Antibody Demonstrates Potent <i>In Vitro</i> and <i>In Vivo</i> Antitumor Activity in Preclinical Models of Small Cell Lung Cancer

Paul Ponath, Daniel L. Menezes, Chin Pan et al. · Clinical Cancer Research · 2018 · 50 citations · Full text

Medicine, Immunology, Oncology +15

1–5 of 16